CKS2, regulated by METTL3, contributes to osteosarcoma progression in an IGF2BP1-dependent manner
Our study identified a METTL3/IGF2BP1-CKS2 axis that promotes OS progression <i>via</i> m<sup>6</sup>A-dependent mRNA stabilization, highlighting CKS2 as a potential therapeutic target.
Authors
- Li Zhang
- Zhiyong Feng
Institutions
- Wuhan Puai Hospital (CN)
Publication Details
- Journal
- International Reviews of Immunology
- Published
- 2026-03-13
- DOI
- https://doi.org/10.1080/08830185.2026.2641449
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00